Evidence map›Paper›PMID 36137905›Full record

ArticleVaccine2022

COVID-19 vaccine hesitancy among Israeli adults before and after vaccines' availability: A cross-sectional national survey.

Dvora Frankenthal, Miri Zatlawi, Ziv Karni-Efrati, Lital Keinan-Boker, Osnat Luxenburg, Michal Bromberg

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Dvora FrankenthalIsrael Center for Disease Control (ICDC), Ministry of Health, Ramat-Gan, Israel. Electronic address: Dvora.frankenthal@moh.gov.il.
Miri ZatlawiIsrael Center for Disease Control (ICDC), Ministry of Health, Ramat-Gan, Israel.
Ziv Karni-EfratiIsrael Center for Disease Control (ICDC), Ministry of Health, Ramat-Gan, Israel; School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel.
Lital Keinan-BokerIsrael Center for Disease Control (ICDC), Ministry of Health, Ramat-Gan, Israel; School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel.
Osnat LuxenburgMedical Technology, Health Information and Research Directorate, Ministry of Health, Jerusalem, Israel.
Michal BrombergIsrael Center for Disease Control (ICDC), Ministry of Health, Ramat-Gan, Israel; School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Israel Ministry of Health · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccine hesitancy (VH) is a major health threat to the efforts to tackle COVID-19 morbidity and mortality. This study's objectives were to assess COVID-19VH before and after vaccines' availability and to analyze the associations between COVID-19VH and participants' characteristics. A national cross-sectional telephone interview survey among Israeli adults aged 21 and older was conducted from September 2020 through May 2021. Attitudes towards COVID-19 vaccines were assessed pre/post vaccines' availability. Multivariate logistic regression analyses were used to identify associations between demographic and health-related characteristics and COVID-19 VH. Most study participants (72.0 % of 2,998) were willing to be vaccinated against COVID-19 across the survey period. The COVID-19 VH declined significantly from 45.6 % pre-vaccine availability to 16.3 % post-vaccine availability (P < 0.001). The multivariable analysis demonstrated that post-vaccine availability, COVID-19 VH was associated with younger age, Arab ethnicity, higher level of religiosity, lower education, past diagnosis of COVID-19, and influenza VH. The main reasons for VH after the vaccine availability included insufficient data on the vaccine (37.4 %) and fear of the vaccine's side effects (33.8 %). Despite the significant decrease in COVID-19 VH following vaccine availability, 16.3% of the population still refuses to get vaccinated. As Israel may face additional waves of the COVID-19 pandemic and booster vaccinations, multimedia vaccine promotions targeting the above-mentioned hesitant populations and their reasons for VH are urgently needed.

Indexed as

COVID-19Influenza VaccinesVaccinesAdultCOVID-19 VaccinesCross-Sectional StudiesHumansIsraelPandemicsVaccinationVaccination HesitancyCOVID-19 VaccinesInfluenza VaccinesVaccinesCOVID-19IsraelSARS-CoV-2Vaccine hesitancyVaccine uptake

Identifiers

PMID36137905
PMCPMC9472961
OpenAlexW4295777541

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.